Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05569161

To Evaluate the Safety and Clinical Radiological Outcomes in 2 Years of Embrance Model Reverse Shoulder Arthroplasty

Prospective Multicentre Longitudinal Study to Evaluate the Safety and Clinical Radiological Outcomes in the First Two Years of the Ambrace Model Reverse Shoulder Arthroplasty.

Status
Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The use of inverted prostheses to replace shoulder joints damaged by degenerative or traumatic processes has become widespread over the past three decades. Current designs, used correctly, can restore function and improve pain in the majority of patients in whom they are implanted. The aim is to carry out a more detailed follow-up of the subjects who are implanted with this prosthetic model on a primary basis, analysing the clinical and radiological results and evaluating the presence of adverse effects of the prosthesis or short-term complications. For this purpose, subjects will be closely monitored for two years.

Detailed description

The use of inverted prostheses to replace shoulder joints damaged by degenerative or traumatic processes has become widespread over the past three decades. Current designs, used correctly, can restore function and improve pain in the majority of patients in whom they are implanted. However, there are complications associated with shoulder arthroplasty surgery, such as wear of the prosthetic components, infection, allergy to the prosthetic components, or failure to restore full shoulder function. The occurrence of these complications is affected by multiple factors dependent on the subject, the surgeon and/or the implant used.

Conditions

Timeline

Start date
2022-03-24
Primary completion
2026-10-31
Completion
2026-10-31
First posted
2022-10-06
Last updated
2024-09-19

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05569161. Inclusion in this directory is not an endorsement.